Drug Approval | April 01, 2025
Morepen secures Loratadine approval for export to China
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
Collaboration combines data, identity capture and Web 3.0 crypto technologies to enhance product safety, traceability, and data integrity for AI systems
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Alkem Medtech to acquire 100% stake of Bombay Ortho
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections
Subscribe To Our Newsletter & Stay Updated
